Potential utility of melatonin as an antioxidant during pregnancy and in the perinatal period

References

• Halliwell B. Free radicals, antioxidants and human disease: curiosity, cause, or consequence? Lancet 1999;344:721–724.
   Google Scholar
• Fridovich I. Oxygen toxicity: a radical explanation. J Exp Biol 1998;201:1203–1209.
   PubMed Web of Science ®Google Scholar
• Gitto E, Reiter RJ, Karbownik M, Tan DX, Gitto P, Barberi S, Barberi I. Causes of oxidative stress in the pre-and perinatal period. Biol Neonate 2002;81:146–157.
   PubMedGoogle Scholar
• Halliwell B. Oxygen radicals as key mediators in neurological disease: fact or fiction? Ann Neurol 1992;32:S10–S15.
   PubMed Web of Science ®Google Scholar
• Saugstad OD. Mechanisms of tissue injury by oxygen radicals: implications for neonatal disease. Acta Paediatr 1996;85:1–4.
   PubMed Web of Science ®Google Scholar
• Sarker AH, Watanabe S, Seki S, Akiyama T, Okada S. Oxygen radical-induced single-strand DNA breaks and repair of the damage in a cell-free system. Mutat Res 1995;337:85–95.
   PubMed Web of Science ®Google Scholar
• Saugstad OD. Bronchopulmonary dysplasia – oxidative stress and antioxidants. Semin Neonatol 2003;8:39–49.
   PubMedGoogle Scholar
• Saugstad OD. Oxidative stress in the newborn – A 30-year perspective. Biol Neonate 2005;88:228–236.
   PubMedGoogle Scholar
• Saugstad OD. Hypoxanthine as an indicator of hypoxia: its role in health and disease through free radical production. Pediatr Res 1988;23:143–150.
   PubMed Web of Science ®Google Scholar
• Haynes RL, Folkerth RD, Keefe RJ, Sung I, Swzeda LI, Rosenberg PA, Volpe JJ, Kinney HC. Nitrosative and oxidative injury to premyelinating oligodendrocytes in periventricular leukomalacia. J Neuropathol Exp Neurol 2003;62:441–450.
   PubMed Web of Science ®Google Scholar
• Clyman RI, Saugstad OD, Mauray F. Reactive oxygen metabolites relax the lamb ductus arteriosus by stimulating prostaglandin production. Circ Res 1989;64:1–8.
   PubMed Web of Science ®Google Scholar
• Archer SL, Peterson D, Nelson DP, De Master EG, Kelly B, Eaton JW, Weir EK. Oxygen radicals and antioxidant enzymes alter pulmonary vascular reactivity in the rat lung. J Appl Physiol 1989;66:102–111.
   PubMed Web of Science ®Google Scholar
• Sanderud J, Bjoro K, Saugstad OD. Oxygen radicals stimulate thromboxane and prostacyclin synthesis and induce vasoconstriction in pig lungs. Scand J Clin Lab Invest 1993;53:447–455.
   PubMed Web of Science ®Google Scholar
• Tan DX, Chen LD, Poeggeler B, Manchester LC, Reiter RJ. Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr J 1993;1:57–60.
   Google Scholar
• Allegra M, Reiter RJ, Tan DX, Gentile C, Tesoriere L, Livrea MA. The chemistry of melatonin's interaction with reactive species. J Pineal Res 2003;34:1–10.
   PubMed Web of Science ®Google Scholar
• Jarzynka MJ, Passey DK, Johnson DA, Konduro NV, Fitz NF, Radio NM, Rasenick M, Benloucif S, Melan MA, Witt-Enderby PA. Microtubules modulate melatonin receptors involved in phase shifting circadian activity rhythms: in vitro and in vivo evidence. J Pineal Res 2009;46:161–171.
   PubMed Web of Science ®Google Scholar
• Reiter RJ. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr Rev 1991;12:151–180.
   PubMed Web of Science ®Google Scholar
• Reiter RJ, Paredes SD, Manchester LC, Tan DX. Reducing oxidative/nitrosative stress: a newly-discovered genre for melatonin. Crit Rev Biochem Mol Biol 2009;44:175–200.
   PubMed Web of Science ®Google Scholar
• Reiter RJ, Tan DX, Manchester LC, Terron MP, Flores LJ, Koppisetti SD. Medical implications of melatonin: receptor-mediated and receptor-independent actions. Adv Med Sci 2007;52:11–28.
   PubMed Web of Science ®Google Scholar
• Reiter RJ, Tan DX, Fuentes-Broto L. Melatonin: a multitasking molecule. Progr Brain Res 2010;181:127–150.
   PubMed Web of Science ®Google Scholar
• Reiter RJ. Melatonin: lowering the high price of free radicals. News Physiol Sci 2000;15:246–250.
   PubMedGoogle Scholar
• Hardeland R, Tan DX, Reiter RJ. Kynuramines, metabolites of melatonin and other indoles: the resurrection of an almost forgotten class of biogenic amines. J Pineal Res 2009;46:109–126.
   Google Scholar
• Paradies G, Petrosillo G, Paradies V, Reiter RJ, Ruggiero FM. Melatonin, cardiolipin and mitochondrial bioenergetics in health and disease. J Pineal Res 2010;48:297–310.
   PubMed Web of Science ®Google Scholar
• Leon J, Acuna-Castroviejo D, Sainz, RM, Mayo JC, Tan DX, Reiter RJ. Melatonin and mitochondrial malfunction. Life Sci 2004;75:765–790.
   PubMed Web of Science ®Google Scholar
• Jou MJ, Peng TI, Hsu LF, Jou SB, Reiter RJ, Yang CM, Chiao CC, Lin YF, Chen CC. Visualization of melatonin’s multiple mitochondrial levels of protection against mitochondiral Ca2+-mediated permeability transition and beyond in rat brain astrocytes. J Pineal Res 2010;48:20–38.
   PubMed Web of Science ®Google Scholar
• Pablos MI, Reiter RJ, Ortiz GG, Guerrero JM. Rhythms of glutathione peroxidase and glutathione reductase in brain or chick and their inhibition by light. Neurochem Int 1998;32:69–75.
   PubMed Web of Science ®Google Scholar
• Barlow-Walden LR, Reiter RJ, Abe M, Pablos MI, Menendez-Pelaez A, Chen LD, Poeggeler B. Melatonin stimulates glutathione peroxidase activity. Neurochem Int 1995;26:497–502.
   PubMed Web of Science ®Google Scholar
• Mohan N, Sadeghi K, Reiter RJ, Meltz ML. The neurohormone melatonin inhibits cytosine, mitogen and ionizing radiation induced NF-κB. Biochem Mol Biol Int 1995;37:1063–1070.
   PubMedGoogle Scholar
• Chuang JI, Mohan N, Meltz ML, Reiter RJ. Effect of melatonin of NF-κB DNA-binding activity in rat spleen. Cell Biol Int 1996;20:687–692.
   PubMed Web of Science ®Google Scholar
• Sewerynek E, Reiter RJ, Melchiorri D, Ortiz GG, Lewinski A. Oxidative damage in the liver induced by ischemia-reperfusion: protection by melatonin. Hepatogastroenterology 1996;43:898–905.
   PubMedGoogle Scholar
• Drazen DL, Nelson RJ. Melatonin receptor subtype MT2 (Mel 1b) and not MT1 (Mel 1a) is associated with melatonin-induced enhancement of cell-mediated and humoral immunity. Neuroendocrinology 2001;74:178–184.
   PubMed Web of Science ®Google Scholar
• Carrillo-Vico A, Guerrero JM, Lardone PJ, Reiter RJ. A review of the multiple actions of melatonin on the immune system. Endocrine 2005;27:189–200.
   PubMed Web of Science ®Google Scholar
• Bengtsson MW, Jedstedt G, Flemstrom G. Duodenal bicarbonate secretion in rats: stimulation by intra-arterial and luminal guanylin and uroguanylin. Acta Physiol Scand 2007;191:309–317.
   Google Scholar
• Nelson CS, Marino JL, Allen CN. Melatonin receptor potentiation of cyclic AMP and the cystic fibrosis transmembrane conductance regulator ion channel. J Pineal Res 1999;26:113–121.
   PubMed Web of Science ®Google Scholar
• Legris GJ, Will PC, Hopfer U. Inhibition of amiloride-sensitive sodium conductance by indoleamines. Proc Nat Acad Sci U S A 1982;79:2046–2050.
   PubMed Web of Science ®Google Scholar
• Sjoblom M, Flemstrom G. Melatonin in the duodenal lumen is a potent stimulant of mucosal bicarbonate secretion. J Pineal Res 2003;34:288–293.
   PubMed Web of Science ®Google Scholar
• Tekbas OF, Ogur R, Korkmaz A, Kilic A, Reiter RJ. Melatonin as an antibiotic: new insights into the actions of this ubiquitous molecule. J Pineal Res 2008;44:222–226.
   PubMed Web of Science ®Google Scholar
• Wisdom SJ, Wilson R, Mckillop JH, Walker JJ. Antioxidant systems in normal pregnancy and in pregnancy hypertension. Am J Obstet Gynecol 1991;6:1701–1705.
   Google Scholar
• Walsh SW, Wang Y. Secretion of lipid peroxides by the human placenta. Am J Obstet Gynecol 1993;169:1462–1466.
   PubMed Web of Science ®Google Scholar
• Walsh SW, Wang Y, Jesse R. Peroxide induces vasoconstriction in the human placenta by stimulating thromboxane. Am J Obstet Gynecol 1993;169:1007–1012.
   PubMed Web of Science ®Google Scholar
• Walsh SW, Vaughan JE, Wang Y, Roberts LJ. Placental isoprostane is significantly increased in preeclampsia. FASEB J 2000;14:1289–1296.
   PubMed Web of Science ®Google Scholar
• Hubel CA. Oxidative stress in the pathogenesis of preeclampsia. Proc Soc Exp Biol Med 1999;222:222–235.
   PubMed Web of Science ®Google Scholar
• Gupta S, Agarwal A, Sharma RK. The role of placental oxidative stress and lipid peroxidation in preeclampsia. Obstet Gynecol Surv 2005;60:807–816.
   PubMed Web of Science ®Google Scholar
• Vanderlelie J, Venardos K, Clifton VL, Gude NM, Clarke FM, Perkins AV. Increased biological oxidation and reduced antioxidant enzyme activity in preeclamptic placentae. Placenta 2005;26:53–58.
   PubMed Web of Science ®Google Scholar
• Atamer Y, Kocyigit Y, Yokus B, Atamer A, Erden AC. Lipid peroxidation, antioxidant defense, status of trace metals and leptin levels in preeclampsia. Eur J Obstet Gynecol Reprod Biol 2005;119:60–66.
   PubMed Web of Science ®Google Scholar
• Walsh SW, Wang Y. Deficient glutathione peroxidase activity in preeclampsia is associated with increased placental production of thromboxane and lipid peroxides. Am J Obstet Gynecol 1993;169:1456–1461.
   PubMed Web of Science ®Google Scholar
• Walsh SW, Wang Y. Trophoblast and placental villous coreproduction of lipid peroxides, thromboxane, and prostacyclin in preeclampsia. J Clin Endocrinol Metab 1995;80:1888–1893.
   PubMed Web of Science ®Google Scholar
• Many A, Hubel CA, Fisher SJ, Roberts JM, Zhou Y. Invasive cytotrophoblasts manifest evidence of oxidative stress in preeclampsia. Am J Pathol 2000;156:321–331.
   PubMed Web of Science ®Google Scholar
• Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996;271:C1424–C1437.
   PubMed Web of Science ®Google Scholar
• Poranen AK, Ekblad U, Uotila P, Ahotupa M. Lipid peroxidation and antioxidants in normal and pre-eclamptic pregnancies. Placenta 1996;17:401–405.
   PubMed Web of Science ®Google Scholar
• Wang Y, Walsh SW. Antioxidant activities and mRNA expression of superoxide dismutase, catalase, and glutathione peroxidase in normal and preeclamptic placentas. J Soc Gynecol Investig 1996;3:179–184.
   PubMedGoogle Scholar
• Cummings DR. Human birth seasonality and sunshine. Am J Human Biol 2010;22:316–324.
   PubMed Web of Science ®Google Scholar
• Bronson FH. Seasonal variation in human reproduction: environmental factors. Q Rev Biol 1995;70:141–164.
   PubMed Web of Science ®Google Scholar
• Henkel R, Menkveld R, Kleinhappl M, Schill WB. Seasonal changes in human sperm chromatin condensation. J Assist Reprod Genet 2001;18:371–377.
   PubMed Web of Science ®Google Scholar
• Partonen T. Short note: melatonin-dependent infertility. Med Hypotheses 1999;52:269–270.
   PubMedGoogle Scholar
• Okatani Y, Sagara Y. Enhanced nocturnal melatonin secretion in women with functional secondary amenorrhea: relationship to opioid system and endogenous estrogen levels. Horm Res 1995;43:194–199.
   PubMedGoogle Scholar
• Walker AB, English J, Arendt J, MacFarlane JA. Hypogonadotrophic hypogonadism and primary amenorrhea associated with increased melatonin secretion from a cystic pineal lesion. Clin Endocr (Oxf) 1996;45:353–356.
   PubMed Web of Science ®Google Scholar
• Bellastella A, Sinisi AA, Criscuolo T, De Bellis A, Carella C, Iono S, Sinisi AM, Pariato F, Venditto T, Pisano G. Melatonin and the pituitary-thyroid axis status in blind adults: a possible resetting after puberty. Clin Endocrinol (Oxf) 1995;43:707–711.
   PubMed Web of Science ®Google Scholar
• Bellastella A, Criscuolo T, Sinisi AA, Iorio S, Mazzuca A, Pariato F, Faggianao M. Influence of blindness on plasma luteinizing hormone, follicle-stimulating hormone, prolactin, and testosterone levels in prepubertal boys. J Clin Endocrinol Metab 1987;64:862–864.
   PubMed Web of Science ®Google Scholar
• Woo MM, Tai CJ, Kang SK, Nathwani PS, Pang SF, Leung PC. Direct action of melatonin in human granulosa-luteal cells. J Clin Endocrinol Metab 2001;86:4789–4797.
   PubMed Web of Science ®Google Scholar
• Nakamura Y, Tamura H, Takayama H, Kato H. Increased endogenous level of melatonin in preovulatory human follicles does not directly influence progesterone production. Fertil Steril 2003;80:1012–1016.
   PubMed Web of Science ®Google Scholar
• Takasaki A, Kakamura Y, Tamura H, Sugino N. Melatonin as a new drug for improving oocyte quality. Reprod Med Biol 2003;2:139–144.
   PubMedGoogle Scholar
• Tamura H, Takasaki A, Miwa I, Taniguchi K, Maekawa R, Asada H, Taketani T, Matsuoka A, Yamagata Y, Shimamura K, et al. Oxidative stress impairs oocyte quality and melatonin protects oocytes from free radical damage and improves fertilization rate. J Pineal Res 2008;44:280–287.
   PubMed Web of Science ®Google Scholar
• Reppert SM. Maternal entrainment of the developing circadian system. Ann NY Acad Sci 1985;453:162–169.
   PubMed Web of Science ®Google Scholar
• Kivela A. Serum melatonin during human pregnancy. Acta Endocrinol (Copenhagen) 1991;124:233–237.
   PubMedGoogle Scholar
• Jimenez-Jorge S, Guerrero JM, Jimenez-Caliani AJ, Naranjo MC, Lardone PJ, Carrillo-Vico A, Osuna C, Molinero P. Evidence for melatonin synthesis in the rat brain during development. J Pineal Res 2007;42:240–246.
   PubMed Web of Science ®Google Scholar
• Tauman R, Zisapel N, Laudon M, Nehama H, Sivan Y. Melatonin production in infants. Pediatr Neurol 2002;26:379–382.
   PubMed Web of Science ®Google Scholar
• Seron-Ferre M, Torres-Farfan C, Forcelledo ML, Valenzuela GJ. The development of circadian rhythms in the fetus and neonate. Semin Perinatol 2001;25:363–370.
   PubMed Web of Science ®Google Scholar
• Reppert SM, Schwartz WJ. Functional activity of the suprachiasmatic nucleus in the fetal primate. Neurosci Lett 1984;46:145–149.
   PubMed Web of Science ®Google Scholar
• Thomas L, Purvis CC, Drew JE, Abramovich DR, Williams LM. Melatonin receptors in human fetal brain. J Pineal Res 2002;33:218–224.
   PubMed Web of Science ®Google Scholar
• Wu YH, Zhou JN, Balesar R, Unmehopa V, Bao A, Jockers R, Van Heerikhuize J, Swaab DF. Distribution of MT1 melatonin receptor immunoreactivity in the human hypothalamus and pituitary gland. J Comp Neurol 2006;499:897–910.
   PubMed Web of Science ®Google Scholar
• Marra G, Anti M, Percesepe A, Armelao A, Ficarelli R, Coco C, Rinelli A, Vecchio FM, D’Arcangelo E. Circadian variations of epithelial cell proliferation in human rectal crypts. Gastroenterology 1994;106:982–987.
   PubMed Web of Science ®Google Scholar
• Reiter RJ, Tan DX, Maldonado MD. Melatonin as an antioxidant: physiology versus pharmacology. J Pineal Res 2005;39:215–216.
   PubMed Web of Science ®Google Scholar
• Hardeland R. Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance. Endocrine 2005;27:119–130.
   PubMed Web of Science ®Google Scholar
• Tan DX, Reiter RJ, Manchester LC, Yan MT, El-Sawi M, Sainz RM, Mayo JC, Kohen R, Allegra M, Hardeland R. Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger. Curr Top Med Chem 2002;2:181–188.
   PubMedGoogle Scholar
• Tan DX, Manchester LC, Tevron MP, Flores LJ, Reiter RJ. One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J Pineal Res 2007;42:28–42.
   PubMed Web of Science ®Google Scholar
• Mayo JC, Sainz RM, Antonlin I, Herrera F, Martin V, Rodriguez C. Melatonin regulation of antioxidant enzyme gene expression. Cell Mol Life Sci 2002;59:1706–1713.
   PubMed Web of Science ®Google Scholar
• Garcia-Perganeda A, Pozo D, Guerrero JM, Calvo JR. Signal transduction for melatonin in human lymphocytes: involvement of a pertussis–toxin sensitive G protein. J Immunol 1997;159:3774–3781.
   PubMed Web of Science ®Google Scholar
• Barjavel MJ, Mamdouh Z, Raghbate N, Bakouche O. Differential expression of the melatonin receptor in human monocytes. J Immunol 1998;160:1191–1197.
   PubMed Web of Science ®Google Scholar
• Lopez-Gonzalez MA, Calvo JR, Segura JJ. Characterization of melatonin binding sites in human peripheral blood neutrophils. Biotech Ther 1993;4:253–262.
   PubMedGoogle Scholar
• Saito S. Cytokine network at the feto-maternal interface. J Reprod Immunol 2001;47:87–103.
   Web of Science ®Google Scholar
• Currier NL, Sun LZY, Miller SC. Exogenous melatonin: quantitative enhancement in vivo of cells mediating non-specific immunity. J Neuroimmunol 2000;104:101–108.
   PubMed Web of Science ®Google Scholar
• Tabiasco J, Rabot M, Aguerre-Girr M, ElCosta H, Berrebi A, Parant O, Laskarin G, Juretic K, Bensussan A, Rukavina D, et al. Human decidual NK cells: unique phenotype and functional properties – a review. Placenta 2006;27:s34–s39.
   PubMed Web of Science ®Google Scholar
• Brzezinski A, Fibich T, Cohen M, Schenker JG, Laufer N. Effects of melatonin on progesterone production by human granulosa lutein cells in culture. Fertil Steril 1992;58:526–529.
   PubMed Web of Science ®Google Scholar
• Zisapel N. Melatonin-dopamine interactions: from basic neurochemistry to a clinical setting. Cell Mol Neurobiol 2002;21:605–616.
   Web of Science ®Google Scholar
• Juszaczak M, Stempniak B. Melatonin inhibits the substance P-induced secretion of vasopressin and oxytocin from the rat hypothalamo-neurohypophysial system: in vitro studies. Brain Res Bull 2003;59:393–397.
   PubMed Web of Science ®Google Scholar
• Jauniaux E, Hempstock J, Greenwold N, Burton GJ. Trophoblastic oxidative stress in relation to temporal and regional differences in maternal placental blood flow in normal and abnormal early pregnancies. Am J Pathol 2003;162:115–125.
   PubMed Web of Science ®Google Scholar
• Wiktor H, Kankofer M, Schmerold I. Oxidative DNA damage in placentas from normal and preeclamptic pregnancies. Virchow Arch 2004;445:74–78.
   PubMed Web of Science ®Google Scholar
• Atamer Y, Kocyigit Y, Yokus B, Dada KA, Lopucki M, Niedermüller H. Lipid peroxidation, antioxidant defense, status of trace metals and leptin levels in preeclampsia. Eur J Obstet Gynecol Reprod Biol 2005;119:60–66.
   PubMed Web of Science ®Google Scholar
• Simko F, Paulis L. Melatonin as a potent antihypertensive treatment. J Pineal Res 2007;42:319–322.
   PubMed Web of Science ®Google Scholar
• Reiter RJ, Tan DX, Korkmaz A. The circadian melatonin rhythm and its modulation: possible impact on hypertension. J Hyperten 2009;27 (Suppl 6):S17–S20.
   Google Scholar
• Cagnacci A, Arangino A, Angiolucci M, Maschio E, Melis GB. Influences of melatonin administration on the circulation of women. Am J Physiol 1998;81:29–33.
   Google Scholar
• Escames G, Khaldy H, Leon J, Gonzalez L, Acuna-Castroviejo D. Changes in iNOS activity, oxidative stress and melatonin levels in hypertensive patients treated with lacidipine. J Hypertens 2004;22:629–635.
   PubMed Web of Science ®Google Scholar
• Scheer FAJL, Van Montfrans GA, Somersen EJW, Mairoho J, Buijs RM. Daily nighttime melatonin reduces blood pressure in male subjects with essential hypertension. Hypertension 2004;43:192–197.
   PubMed Web of Science ®Google Scholar
• Cornelissen G, Sitka U, Tarquini B, Mainardi G, Panero C, Cugini P, Weinert D, Romoli F, Cassanas G, Maggioni C, et al. Chronobiologic approach to blood pressure during pregnancy and early extrauterine life. Prog Clin Biol Res 1990;341a:585–594.
   PubMedGoogle Scholar
• Nakamura Y, Tamura H, Kashida S, Takayama H, Yamagata Y, Karube A, Sugino N, Kato H. Changes of serum melatonin level and its relationship to fetoplacental unit during pregnancy. J Pineal Res 2001;30:29–33.
   PubMed Web of Science ®Google Scholar
• Tranquilli AL, Turi A, Giannubilo, Garbati E. Circadian melatonin concentration rhythm is lost in pregnant women with altered blood pressure rhythm. Gynecol Endocrinol 2004;18:124–129.
   PubMed Web of Science ®Google Scholar
• Peled N, Shorer Z, Peled E, Pillar G. Melatonin effect on seizures in children with severe neurologic deficit disorders. Epilepsia 2001;42:1208–1210.
   PubMed Web of Science ®Google Scholar
• Molina-Carballo A, Munoz-Hoyos A, Reiter RJ, Sanchez-Forte M, Moreno-Madrid F, Rufo-Campos M, Molina-Font JA, Acuna-Castroviego D. Utility of high doses of melatonin as adjunctive anticonvulsant therapy in a child with severe myoclonic epilepsy: two years experience. J Pineal Res 1997;23:97–105.
   PubMed Web of Science ®Google Scholar
• Sharkey JT, Cable C, Olcese J. Melatonin synergizes with oxytocin to enhance contractility of human myometrial smooth muscle cells. J Clin Endocrinol 2009;94:421–427.
   PubMed Web of Science ®Google Scholar
• Yuo JH, Carter LB, Reiter RJ, Jevtovic-Todorovic V. Melatonin reduces the severity of anesthesia-induced apoptotic neurodegeneration in the developing rat brain. Neurobiol Dis 2006;25:522–530.
   Google Scholar
• Wakatsuki A, Okatani Y, Lzumiya C, Ikenoue N. Melatonin protects against ischemia and reperfusion oxidative and lipid damage in fetal rat brain. J Pineal Res 1999;26:147–152.
   PubMed Web of Science ®Google Scholar
• Milczarek R, Hollmann A, Sokolowska E, Kaletha K, Klimek J. Melatonin enhances antioxidant action of α-tocopherol and ascorbate against NADPH- and iron-dependent lipid peroxidation in human placental mitochondria. J Pineal Res 2010;49:149–155.
   PubMed Web of Science ®Google Scholar
• Tamura H, Nakamura Y, Terron MP, Flores LJ, Manchester LC, Tan DX, Sugino N, Reiter RJ. Melatonin and pregnancy in the human. Reprod Toxicol 2008;25:291–303.
   PubMed Web of Science ®Google Scholar
• Rizzo P, Raffone E, Benedetto V. Effect of the treatment with myo-inositol plus folic acid plus melatonin in comparison with a treatment with myo-inositol plus folic acid on oocyte quality and pregnancy outcome in IVF cycles. A prospective, clinical trial. Eur Rev Med Pharmacol Sci 2010;14:555–561.
   PubMed Web of Science ®Google Scholar
• Golightly E, Jabbour HN, Norman JE. Endocrine immune interactions in human parturition. Mol Cell Endocrinol 2011;335:52–59.
   PubMed Web of Science ®Google Scholar
• Shoji H, Koletzko B. Oxidative stress and antioxidant protection in the perinatal period. Curr Opin Clin Nutr Metab Care 2007;10:324–328.
   PubMed Web of Science ®Google Scholar
• Auguelles S, Markado MJ, Ayala A. Correlation between circulating biomarkers of oxidative stress of maternal and umbilical cord blood at birth. Free Radic Res 2006;40:565–570.
   PubMed Web of Science ®Google Scholar
• Fogel I, Pinchuk I, Kupferminc MJ, Lichtenberg D, Fainarn O. Oxidative stress in the fetal circulation does not depend on mode of delivery. Am J Obstet Gynecol 2005;193:241–246.
   PubMed Web of Science ®Google Scholar
• Hracsko Z, Safar Z, Orvos H, Novak Z, Pal A, Varga IS. Evaluation of oxidative stress markers after vaginal delivery or caesarean section. In Vivo 2007;21:703–706.
   PubMed Web of Science ®Google Scholar
• Laurie S, Mataz Z, Boaz M, Fux A, Golan A, Sadan O. Different degrees of fetal oxidative stress in elective and emergent caesarean section. Neonatology 2007;92:111–115.
   PubMed Web of Science ®Google Scholar
• Scher M. Perinatal asphyxia: timing and mechanisms of injury in neonatal encephalopathy. Curr Neurol Neurosci Rep 2001;1:175–184.
   PubMedGoogle Scholar
• Harris ED. Regulation of antioxidant enzymes. FASEB J 1992;6:2675–2683.
   PubMed Web of Science ®Google Scholar
• Palmer C, Brucklacher RM, Christensen MA, Vannucci RC. Carbohydrate and energy metabolism during the evolution of hypoxic-ischemic brain damage in the immature rat. J Cereb Blood Flow Metab 1990;10:227–235.
   PubMed Web of Science ®Google Scholar
• Yager JY, Brucklacher RM, Vannucci RC. Cerebral energy metabolism during hypoxia-ischemia and early recovery in immature rats. Am J Physiol 1992;262:H672–H677.
   PubMedGoogle Scholar
• Berger R, Gjedde A, Heck J, Müller E, Kriegistein J, Jensen A. Extension of the 2-deoxyglucose method to the fetus in utero: theory and normal values for the cerebral glucose consumption in fetal guinea pigs. J Neurochem 1994;63:271–279.
   PubMed Web of Science ®Google Scholar
• Vannucci RC, Christensen MA, Yager JY. Nature, time-course and extent of cerebral edema in the perinatal hypoxic-ischemic brain damage. Pediatr Neurol 1993;9:29–34.
   PubMed Web of Science ®Google Scholar
• Berger R, Garnier J. Perinatal brain injury. J Perinatol Med 2000;28:261–285.
   PubMed Web of Science ®Google Scholar
• Halliwell B, Gutteridge JC. Role of free radicals and catalytic ions in human disease: an overview. Meth Enzymol 1990;186:1–85.
   PubMed Web of Science ®Google Scholar
• Buonocore G, Zani S, Sargentini I, Gioia D, Signorini C, Bracci R. Hypoxia-induced free iron released in the red cells of newborn infants. Acta Pediatr 1998;87:77–81.
   PubMed Web of Science ®Google Scholar
• Ferrali M, Signorini C, Ciccoli L, Comporti M. Iron release and membrane damage in erythrocytes exposed to oxidizing agents, phenylhydrazine, divicine and isouramil. Biochem J 1992;285:295–301.
   PubMed Web of Science ®Google Scholar
• Buonocore G, Gioia D, DeFilippo M, Piccolini E, Bracci R. Superoxide anion release by polymorphonuclear leukocytes in whole blood of newborns and mothers during the peripartal period. Pediatr Res 1994;36:619–622.
   PubMed Web of Science ®Google Scholar
• Crow JP, Beckman JS. The importance of superoxide in nitric-oxide-dependent toxicity: evidence for peroxynitrite-mediated injury. Adv Exp Med Biol 1996;387:147–161.
   PubMedGoogle Scholar
• Szabo C, Oshima H. DNA damage induced by peroxynitrite: subsequent biological effects. Nitric Oxide 1997;1:373–385.
   PubMed Web of Science ®Google Scholar
• Crow JP, Beckman JS. The role of peroxynitrite in nitric oxide-mediated toxicity. Curr Top Microbiol Immunol 1995;196:57–73.
   PubMedGoogle Scholar
• Phelps DT, Ferro TJ, Higgins PJ, Shankar R, Parker DM, Johnson A. TNF-α induces peroxynitrite-mediated depletion of lung endothelial glutathione via protein kinase C. Am J Physiol 1995;269:551–559.
   PubMed Web of Science ®Google Scholar
• Inoue S, Kawanishi S. Oxidative DNA damage induced by simultaneous generation of nitric oxide and peroxide. FEBS Lett 1995;371:86–88.
   PubMed Web of Science ®Google Scholar
• Salgo MG, Bermuzed E, Squadrito G, Pryor W. DNA damage and oxidation of thiol peroxynitrite causes in rat thymocytes. Arch Biochem Biophys 1995;322:500–505.
   PubMed Web of Science ®Google Scholar
• Szabo C, Cuzzocrea S, Zingarelli B, O’Connor M, Salzman AL. Endothelial dysfunction in endotoxic shock: importance of the activation of poly (ADP ribose) synthetase (PARS) by peroxynitrite. J Clin Invest 1997;100:723–735.
   PubMed Web of Science ®Google Scholar
• Kothecha S. Lung growth: implication for the newborn infant. Arch Dis Child Fetal Neonatal 2000;82:F69–F74.
   PubMed Web of Science ®Google Scholar
• Bhandari V, Mauli KN, Kresch M. Hyperoxia causes an increase in antioxidant enzyme activity in adult and fetal rat type II pneumocytes. Lung 2000;178:53–60.
   PubMed Web of Science ®Google Scholar
• Ikegami M, Kallapur S, Michna J, Jobe AH. Lung injury and surfactant metabolism after hyperventilation of premature lambs. Pediatr Res 2000;47:398–404.
   PubMed Web of Science ®Google Scholar
• Lamb NJ, Gutteridge JMC, Baker C, Evans TW, Quinlan GJ. Oxidative damage to proteins of bronchoalveolar lavage fluid in patients with acute respiratory distress syndrome: evidence for neutrophil-mediated hydroxylation, nitration and chlorination. Intens Care Med 1999;25:1738–1744.
   Google Scholar
• Huertas JR, Palomino N, Ochoa JJ, Quiles JL, Ramirez-Tortosa MC, Battino M, Robles R, Mataix J. Lipid peroxidation and antioxidant erythrocyte membranes of full-term and preterm newborns. Biofactors 1998;8:133–137.
   PubMed Web of Science ®Google Scholar
• Esteban J, Morcillo JE, Cortjo J. Oxidative stress and pulmonary inflammation: pharmacological intervention with antioxidants. Pharmacol Res 1999;40:393–404.
   PubMed Web of Science ®Google Scholar
• Boda D, Nemeth I, Pinter S. Surface tension, glutathione content and redox ratio of the tracheal aspirate fluid of premature infants with IRDS. Biol Neonate 1998;74:281–288.
   PubMedGoogle Scholar
• Banks BA, Ischiropoulos H, McClelland M, Ballard PL, Ballard RA. Plasma 3-nitrotyrosine is elevated in premature infants who develop bronchopulmonary dysplasia. Pediatrics 1998;101:870–874.
   PubMed Web of Science ®Google Scholar
• Dellinger RP. Inhaled nitric oxide in acute lung injury and acute respiratory distress syndrome. Inability to translate physiologic benefit to clinical outcome benefit in adult clinical trials. Intens Care Med 1999;25:881–883.
   PubMed Web of Science ®Google Scholar
• Janssen YMW, Soultanakis R, Steece K, Heerdt E, Singh RJ, Joseph J, Kalyanaraman B. Depletion of nitric oxide causes cell cycle alterations, apoptosis and oxidative stress in pulmonary cells. Am J Physiol 1998;275:L1100–L1109.
   PubMedGoogle Scholar
• Kim K, Whitin JC, Sukhova NM, Cohen HJ. Increases in extracellular glutathione peroxidase in plasma and lungs of mice exposed to hyperoxia. Pediatr Res 1999;46:715–721.
   PubMed Web of Science ®Google Scholar
• Ogihara T, Hirano K, Morinobu T, Kim HS, Hiroi M, Ogihara H, Tamai H. Raised concentrations of aldehyde lipid peroxidation products in premature infants with chronic lung disease. Arch Dis Child Fetal Neonatal Ed 1999;80:F21–F25.
   PubMed Web of Science ®Google Scholar
• Metnitz PGH, Bartens C, Fisher M, Fridich P, Steltzer H, Druml W. Antioxidant status in patient with acute respiratory distress syndrome. Intens Care Med 1999;25:180–185.
   PubMed Web of Science ®Google Scholar
• Vento G, Mele MC, Mordente A, Romagnoli C, Matassa PG, Zecca E, Zeppacosta B, Persichilli S. High total antioxidant activity and uric acid in tracheobronchial aspirate fluid of preterm infants during oxidative stress: an adaptive response to hyperoxia? Acta Paediatr 2000;89:336–342.
   PubMed Web of Science ®Google Scholar
• Yitig S, Yurdakok M, Kilinc K, Oran O, Erdem G, Tekinalp G. Serum malondialdehyde concentrations as a measure of oxygen free radical damage in preterm infants. Turk J Pediatr 1998;40:177–183.
   PubMed Web of Science ®Google Scholar
• Perez EM, Weisman LE. Novel approaches to the prevention and therapy of neonatal bacterial sepsis. Clin Perinatol 1997;24:213–225.
   PubMed Web of Science ®Google Scholar
• Antonielli M. Sepsis and septic shock: pro-inflammatory or anti-inflammatory state? J Chemother 1999;6:536–540.
   Google Scholar
• Lush CW, Kvietys PR. Microvascular dysfunction in sepsis. Microcirculation 2000;7:83–101.
   PubMed Web of Science ®Google Scholar
• Cohen J. The immunopathogenesis of sepsis. Nature 2002;420:885–891.
   PubMed Web of Science ®Google Scholar
• Abraham E, Singer M. Mechanisms of sepsis-induced organ dysfunction. Crit Care Med 2007;35:2408–2416.
   PubMed Web of Science ®Google Scholar
• Basit A, Reutershan J, Morris MA, Solga M, Rose CE Jr, Ley K. ICAM-1 and LFA-1 play critical roles in LPS-induced neutrophil recruitment into the alveolar space. Am J Physiol Lung Cell Mol Physiol 2006;291:L200–L207.
   PubMed Web of Science ®Google Scholar
• Cepinskas G, Savickiene J, Ionescu, CV, Kvietys PR. PMN transendothelial migration decreases nuclear NFkappaB in IL-1beta-activated endothelial cells: role of PECAM-1. J Cell Biol 2003;161:641–651.
   PubMed Web of Science ®Google Scholar
• Ley K, Reutershan J. Leucocyte-endothelial interactions in health and disease. Handb Exp Pharmacol 2006;176 (Pt 2):97–133.
   Google Scholar
• Rawlingson A. Nitric oxide, inflammation and acute burn injury. Burns 2003;29:631–640.
   PubMed Web of Science ®Google Scholar
• Razavi HM, Wang L, Weicker S, Ouinlan GJ, Mumby S, McCormack DG, Mehta S. Pulmonary oxidant stress in murine sepsis is due to inflammatory cell nitric oxide. Crit Care Med 2005;33:1333–1339.
   PubMed Web of Science ®Google Scholar
• Mochida S, Matsura T, Yamashita A, Horie S, Ohata S, Kusumoto C, Nishida T, Minami Y, Inagaki Y, Ishibe Y, et al. Geranylgeranylacetone ameliorates inflammatory response to lipopolysaccharide (LPS) in murine macrophages: inhibition of LPS binding to the cell surface. J Clin Biochem Nutr 2007;41:115–123.
   PubMed Web of Science ®Google Scholar
• Riedemann NC, Guo RF, Ward PA. Novel strategies for the treatment of sepsis. Nat Med 2003;9:517–524.
   PubMed Web of Science ®Google Scholar
• Liu L, Kubes P. Molecular mechanisms of leukocyte recruitment: organ-specific mechanisms of action. Thromb Haemost 2003;89:213–220.
   PubMed Web of Science ®Google Scholar
• Liu SF, Malik AB. NF-kappa B activation as a pathological mechanism of septic shock and inflammation. Am J Physiol Lung Cell Mol Physiol 2006;290:L622–L645.
   PubMed Web of Science ®Google Scholar
• Abraham E. Nuclear factor-kappa B and its role in sepsis associated organ failure. J Infect Dis 187 2003 (Suppl. 2);S364–S369.
   PubMedGoogle Scholar
• Rao RM, Yang L, Garcia-Cardena G, Luscinskas FW. Endothelial-dependent mechanisms of leukocyte recruitment to the vascular wall. Circ Res 2007;101:234–247.
   PubMed Web of Science ®Google Scholar
• Janssen-Heininger YM, Poynter ME, Baeuerle PA. Recent advances towards understanding redox mechanisms in the activation of nuclear factor kappa B. Free Radic Biol Med 2000;28:1317–1327.
   PubMed Web of Science ®Google Scholar
• Panacek EA, Marshall JC, Albertson TE, Johnson DH, Johnson S, MacArthur RD, Miller M, Barchuk WT, Fischkoff S, Kaul M, et al. Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab′)2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels. Crit Care Med 2004;32:2173–2182.
   PubMed Web of Science ®Google Scholar
• Bernard GR, Vincent JL, Laterre PF, La Rosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001;344:699–709.
   PubMed Web of Science ®Google Scholar
• Abraham E. Effects of recombinant human activated protein C in human models of endotoxin administration. Proc Am Thorac Soc 2005;2:243–247.
   PubMedGoogle Scholar
• Ely EW, Bernard GR, Vincent JL. Activated protein C for severe sepsis. N Engl J Med 2002;347:1035–1036.
   PubMed Web of Science ®Google Scholar
• Batra S, Kumar R, Seema KR, Kapoor AK, Ray G. Alterations in antioxidant status during neonatal sepsis. Ann Trop Pediatr 2000;20:27–33.
   PubMed Web of Science ®Google Scholar
• Seema KR, Mandal RN, Tandon A, Randhawa VS, Mehta G, Batra S, Ray GN, Kapoor AK. Serum TNF-α and free radical scavengers in neonatal septicaemia. Ind J Pediatr 1999;66:511–516.
   PubMedGoogle Scholar
• Kurt AN, Aygun AD, Godekmerdan A, Kurt A, Dogan Y, Yilmaz E. Serum IL-1β, IL-6, IL-8, and TNF-α levels in early diagnosis and management of neonatal sepsis. Mediators Inflamm 2007;2007:31397.
   PubMed Web of Science ®Google Scholar
• Mao GD, Thomas PD, Lopaschuk GD, Poznansky MJ. Superoxide dismutase (SOD)-catalase conjugates. J Biol Chem 1993;268:416–620.
   PubMed Web of Science ®Google Scholar
• Crapo JD, DeLong DM, Sjostrom K, Hasler GR, Drew RT. The failure of aerosolized superoxide dismutase to modify pulmonary oxygen toxicity. Am Rev Respir Dis 1977;115:1027–1033.
   PubMed Web of Science ®Google Scholar
• Matalon S, Holm BA, Baker RR, Whitfield MK, Freeman BA. Characterization of antioxidant activities of pulmonary surfactant mixtures. Biochim Biophys Acta 1990;1035:121–127.
   PubMed Web of Science ®Google Scholar
• Suresh GK, Davis JM, Soll RF. Superoxide dismutase for preventing chronic lung disease in mechanically ventilated preterm infants. Cochrane Database Syst Rev 2001;(1):CD001968.
   PubMedGoogle Scholar
• Crapo J. Superoxide dismutase and tolerance to pulmonary oxygen toxicity. Chest 1975;67:39S–40S.
   PubMed Web of Science ®Google Scholar
• Crapo J, Barrio B, Foscue H, Slaelburne J. Structural and biochemical changes in rat lungs occurring during exposure to lethal and adaptive doses of oxygen. Am Rev Respir Dis 1980;122:123–143.
   PubMed Web of Science ®Google Scholar
• Paegle W, Bernhard W, Turndorf H. Intermittent exposure to 40 percent oxygen prolongs rat survival in 100 percent oxygen. Anesth Analg 1977;56:847–851.
   PubMed Web of Science ®Google Scholar
• Tierney D, Yang J, Ayers L. Enzymatic activity in rat lungs: some changes with exposure to 1 ATM oxygen. Chest 1975;67:40S–42S.
   PubMed Web of Science ®Google Scholar
• Simon L. Protection against toxic effect of sustained hyperoxia on lung macrophages by superoxide dismutase. Clin Res 1980;28:432A.
   Google Scholar
• Block ER, Fisher AB. Protection of hyperoxic-induced depression of pulmonary serotonin clearance by pretreatment with superoxide dismutase. Am Rev Respir 1977;116:441–447.
   PubMed Web of Science ®Google Scholar
• Rosenfeld W, Evans H, Concepcion L, Jhaveri R, Schaeffer H, Friedman A. Prevention of bronchopulmonary dysplasia by administration of bovine superoxide dismutase in preterm infants with respiratory distress syndrome. J Pediatr 1984;105:781–785.
   PubMed Web of Science ®Google Scholar
• Davis JM, Rosenfeld WN, Richter SE, Parad MR, Gewolb IH, Spitzer AR, Carlo WA, Couser RJ, Price A, Flaster E, et al. Safety and pharmacokinetics of multiple doses of recombinant human CuZn superoxide dismutase administered intratracheally to premature neonates with respiratory distress syndrome. Pediatrics 1997;100:24–30.
   PubMed Web of Science ®Google Scholar
• Davis JM, Parad RB, Michele T, Allred E, Price A, Rosenfeld W. North American Recombinant Human CuZnSOD Study Group: pulmonary outcome at 1 year corrected age in premature infants treated at birth with recombinant human CuZn superoxide dismutase. Pediatrics 2003;111:469–476.
   PubMed Web of Science ®Google Scholar
• Frosali S, Di Simplicio P, Perrone S, Di Giuseppe D, Longini M, Tanganelli D, Buonocore G. Glutathione recycling and antioxidant enzyme activities in erythrocytes of term and preterm newborns at birth. Biol Neonate 2004;85:188–194.
   PubMedGoogle Scholar
• Vento M, Asensi M, Sastre J, Lloret A, Garcia-Sala F, Minana JB, Vina J. Hyperoxemia caused by resuscitation with pure oxygen may alter intracellular redox status by increasing oxidized glutathione in asphyxiated newly born infants. Semin Perinatol 2002;26:406–410.
   PubMed Web of Science ®Google Scholar
• Jankov RP, Negus A, Transwell AK. Antioxidants as therapy in the newborn: some word of caution. Pediatr Res 2001;50:681–687.
   PubMed Web of Science ®Google Scholar
• Karp WB, Robertson AF. Vitamin E in neonatology. Adv Pediatr 1986;33:127–147.
   PubMedGoogle Scholar
• Johnson L, Bowen Jr FW, Abbasi S, Hermann N, Weston M, Sacks L, Porat R, Stahl G, Peckham G, Delivoria-Papadopoulos M, et al. Relationship of prolonged pharmacologic serum levels of vitamin E to incidence of sepsis and necrotizing enterocolitis in infants with birth weight 1,500 grams or less. Pediatrics 1985;75:619–638.
   PubMed Web of Science ®Google Scholar
• Podmore ID, Griffiths HR, Herbert KE, Mistry N, Mistry P, Lunec J. Vitamin C exhibits pro-oxidant properties. Nature 1998;392:559.
   PubMed Web of Science ®Google Scholar
• Saldanha RL, Cepeda EE, Poland RL. The effect of vitamin E prophylaxis on the incidence and severity of bronchopulmonary dysplasia. J Pediatr 1982;101:89–93.
   PubMed Web of Science ®Google Scholar
• Brion LP, Bell EF, Rughuveer TS. Vitamin E supplementation for prevention of morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2003;3:CD003665.
   Google Scholar
• Tyson JE, Wright LL, Oh W, Kennedy KA, Mele L, Ehrenkranz RA, Stoll BJ, Lemons JA, Stevenson DK, Bauer CR, et al. Vitamin A supplementation for extremely-low-birth infants National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med 1999;340:1962–1968.
   PubMed Web of Science ®Google Scholar
• Darlow BA, Graham PJ. Vitamin A supplementation for preventing morbidity and mortality in very low birth weight infants. Cochrane Database Syst Rev 2007;17:CD000501.
   Google Scholar
• Wardle SP, Hughes A, Chen S, Shaw NJ. Randomized controlled trial of vitamin A supplementation in preterm infants to prevent chronic lung disease. Arch Dis Child Fetal Neonatal Ed 2001;84:F9–F13.
   PubMed Web of Science ®Google Scholar
• Darlow BA, Winterbourn CC, Inder TE, Graham PJ, Harding JE, Weston PJ, Austin NC, Elder DE, Mogridge N, Boss IH, et al. The effect of selenium supplementation on outcome in very low birth weight infants: a randomized controlled trial. New Zealand Neonatal Study Group. J Pediatr 2000;136:473–480.
   Google Scholar
• Winterbourn CC, Chan T, Buss IH, Inder TE, Mogridge N, Darlow BA. Protein carbonyls and lipid peroxidation products as oxidation markers in preterm infant plasma: associations with chronic lung disease and retinopathy and effects of selenium supplementation. Pediatr Res 2000;48:84–90.
   PubMed Web of Science ®Google Scholar
• Darlow BA, Austin NC. Selenium supplementation to prevent short-term morbidity in preterm neonates. Cochrane Database Syst Rev 2003;4:CD003312.
   Google Scholar
• Marro PJ, Baumgart S, Delivoria-Papadopoulos M, Zirin S, Corcoran L, McGavin SP, Davis LE, Clancy RR. Purine metabolism and inhibition of xanthine oxidase in severely hypoxic neonates going onto extracorporeal membrane oxygenation. Pediatr Res 1997;41(Pt 1):513–520.
   PubMedGoogle Scholar
• Russell GA, Cooke RW. Randomised controlled trial of allopurinol prophylaxis in very preterm infants. Arch Dis Child Fetal Neonatal Ed 1995;73:F27–F31.
   PubMed Web of Science ®Google Scholar
• Chaudari T, McGuire W. Allopurinol for preventing mortality and morbidity in newborn infants with suspected hypoxic-ischaemic encephalopathy. Cochrane Database Syst Rev 2008;2:CD006817.
   Google Scholar
• Stasica P, Ulanski P, Rosiak JM. Melatonin as a hydroxyl radical scavenger. J Pineal Res 1998;25:65–66.
   PubMed Web of Science ®Google Scholar
• Peyrot F, Ducrocq C. Potential role of tryptophan derivatives in stress responses characterized by the generation of reactive oxygen and nitrogen species. J Pineal Res 2008;45:235–246.
   PubMed Web of Science ®Google Scholar
• Li XJ, Zhang LM, Gu J, Zhang AZ, Sun FY. Melatonin decreases production of hydroxyl radical during ischemia-reperfusion. Acta Pharmacol Sin 1997;18:394–396.
   Web of Science ®Google Scholar
• Tan DX, Manchester LC, Reiter RJ, Plummer BF, Hardies LJ, Weintraub ST, Vijayalaxmi, Shepherd AM. A novel melatonin metabolite, cyclic 3-hydroxymelatonin: a biomarker of in vivo hydroxyl radical generation. Biochem Biophys Res Commun 1998;253:614–620.
   PubMed Web of Science ®Google Scholar
• Reiter RJ, Tan DX, Manchester LC, Qi WB. Biochemical reactivity of melatonin with reactive oxygen and nitrogen: a review of the evidence. Cell Biochem Biophys 2001;34:237–256.
   PubMed Web of Science ®Google Scholar
• Zang LY, Cosma G, Gardner H, Vallyatan V. Scavenging of reactive oxygen species by melatonin. Biochim Biophys Acta 1998;1425:467–477.
   Web of Science ®Google Scholar
• Tan DX, Manchester LC, Reiter RJ, Qi WB, Karbownik M, Calvo JR. Significance of melatonin in antioxidative defense system: reactions and products. Biol Signals Recept 2000;9:137–159.
   PubMedGoogle Scholar
• Tan DX, Manchester LC, Burkhardt S, Sainz RM, Mayo JC, Kohen R, Shohami E, Huo YS, Hardeland R, Reiter RJ. N1-acetyl-N2-formyl-5-methoxykynuramine, a biogenic amine and melatonin metabolite, functions as a potent antioxidant. FASEB J 2001;15:2294–2296.
   PubMed Web of Science ®Google Scholar
• Manda K, Ueno M, Anzai K. AFMK, a melatonin metabolite, attenuates X-ray-induced oxidative damage to DNA, proteins and lipids in mice. J Pineal Res 2007;424:386–393.
   Google Scholar
• Hardeland R, Backhaus C, Fadavi A. Reactions of the NO redox forms NO+, *NO and HNO (protonated NO-) with the melatonin metabolite N1-acetyl-5-methoxykynuramine. J Pineal Res 2007;43:382–388.
   PubMed Web of Science ®Google Scholar
• Pieri C, Marra M, Moroni F, Recchioni R, Marcheselli F. Melatonin, a peroxyl radical scavenger more efficient than vitamin E. Life Sci 1994;55:PL271–PL276.
   PubMed Web of Science ®Google Scholar
• Pieri C, Moroni F, Marra M, Marcheselli F, Recchioni R. Melatonin is an efficient antioxidant. Arch Gerontol Geriatrics 1995;20:159–165.
   PubMed Web of Science ®Google Scholar
• Reiter RJ, Tan DX, Osuna C, Gitto E. Actions of melatonin in the reduction of oxidative stress: a review. J Biomed Sci 2000;7:444–458.
   PubMed Web of Science ®Google Scholar
• Hardeland R, Poeggeler B, Pappolla MA. Mitochondrial actions of melatonin – an endeavor to identify their adaptive and cytoprotective mechanisms. Endokrinologie 2009;65:14–31.
   Google Scholar
• Rodríguez C, Mayo JC, Sainz RM, Antolin I, Herrera F, Martin V, Reiter RJ. Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 2004;36:1–9.
   PubMed Web of Science ®Google Scholar
• Kennaway DJ, Stamp GE, Goble FC. Development of melatonin production in infants and the impact of prematurity. J Clin Endocrinol Metab 1992;75:367–369.
   PubMed Web of Science ®Google Scholar
• Kennaway DJ, Goble FC, Stamp GE. Factors influencing the development of melatonin rhythmicity in humans. J Clin Endocrinol Metab 1996;81:1525–1532.
   PubMed Web of Science ®Google Scholar
• Sivan Y, Laudon M, Tauman R, Zisapel N. Melatonin production in healthy infants: evidence for seasonal variations. Pediatr Res 2001;49:63–68.
   PubMed Web of Science ®Google Scholar
• Ardura J, Gutierrez R, Andres J, Agapito T. Emergence and evolution of the circadian rhythm of melatonin in children. Horm Res 2003;59:66–72.
   PubMed Web of Science ®Google Scholar
• Muñoz-Hoyos A, Rodríguez-Cabezas T, Molina-Carballo A, Martínez-Sempere JJ, Ruiz-Cosano C, Acuña-Castroviejo D. Melatonin concentration in the umbilical artery and vein in human preterm and term neonates and neonates with acute fetal distress. J Pineal Res 1992;13:184–191.
   PubMed Web of Science ®Google Scholar
• Muñoz-Hoyos A, Jaldo-Alba F, Molina-Carballo A, Rodríguez-Cabezas T, Molina-Font JA, Acuña-Castroviejo D. Absence of plasma melatonin circadian rhythm during the first 72 h of life in human infants. J Clin Endocrinol Metab 1993;77:699–703.
   PubMed Web of Science ®Google Scholar
• Illnerova H, Buresova M, Presl J. Melatonin rhythm in human milk. J Clin Endocrinol Metab 1993;77:838–841.
   PubMed Web of Science ®Google Scholar
• Cubero J, Valero V, Sanchez J, Rivero M, Parvez H, Rodriguez AB, Barriga C. The circadian rhythm of tryptophan in breast milk affects the rhythms of 6-sulfatoxymelatonin and sleep in newborn. Neuro Endocrinol Lett 2005;26:657–661.
   PubMed Web of Science ®Google Scholar
• Furman L, Minich NM, Hack M. Breast feeding of very low birth weight infants. J Hum Lact 1998;14:29–34.
   PubMedGoogle Scholar
• Furman L, Taylor G, Minich N, Hack M. The effect of maternal milk on neonatal morbidity of very low-birth-weight infants. Arch Pediatr Adolesc Med 2003;157:66–71.
   PubMedGoogle Scholar
• Furman L, Minich N. Efficiency of breastfeeding as compared to bottle-feeding in very low birth weight (VLBW, <1.5 kg) infants. J Perinatol 2004;24:706–713.
   PubMedGoogle Scholar
• Gitto E, Reiter RJ, Sabatino G, Buonocore G, Romeo C, Gitto P, Bugge C, Trimarche G, Barberi I. Correlation among cytokines, bronchopulmonary dysplasia and modality of ventilation in preterm newborns: improvement with melatonin treatment. J Pineal Res 2005;39:287–293.
   PubMed Web of Science ®Google Scholar
• Hamrick SE, Ferriero DM. The injury response in the term newborn brain: can we neuroprotect? Curr Opin Neurol 2003;16:147–154.
   PubMed Web of Science ®Google Scholar
• Miller SL, Yan EB, Castillo-Meléndez M, Jenkin G, Walker DW. Melatonin provides neuroprotection in the late-gestation fetal sheep brain in response to umbilical cord occlusion. Dev Neurosci 2005;27:200–210.
   PubMed Web of Science ®Google Scholar
• Maldonado MD, Murillo-Cabezas F, Terron MP, Flores LJ, Tan DX, Manchester LC, Reiter RJ. The potential of melatonin in reducing morbidity-mortality after craniocerebral trauma. J Pineal Res 2007;42:1–11.
   PubMed Web of Science ®Google Scholar
• Jou MJ, Peng TI, Yu PZ, Jou SB, Reiter RJ, Chen JY, Wu HY, Chen CC, Hsu LF. Melatonin protects against common deletion of mitochondrial DNA-augmented mitochondrial oxidative stress and apoptosis. J Pineal Res 2007;43:389–403.
   PubMed Web of Science ®Google Scholar
• Samantaray S, Das A, Thakore NP, Matzelle, DD, Reiter RJ, Ray SK, Banik NL. Therapeutic potential of melatonin in traumatic central nervous system injury. J Pineal Res 2009;47:134–142.
   PubMed Web of Science ®Google Scholar
• Hong Y, Palaksha KJ, Park K, Park S, Kim HD, Reiter RJ, Chang KT. Melatonin plus excercise-based neurorehabilitative therapy for spinal cord injury. J Pineal Res 2010;49:201–209.
   PubMed Web of Science ®Google Scholar
• Kennaway DJ, Flanagan DE, Moore VM, Cockington RA, Robinson JS, Phillips DI. The impact of fetal size and length of gestation on 6-sulphatoxymelatonin excretion in adult life. J Pineal Res 2001;30:188–192.
   PubMed Web of Science ®Google Scholar
• Griefahn B, Blaszkewicz M, Brode P, Remer T. Do birth variable data predict melatonin production in 8- to 9-year-old children? Analysis of excreted 6-sulfatoxymelatonin. Horm Res 2004;62:156–160.
   PubMedGoogle Scholar
• Muñoz-Hoyos A, Bonillo-Perales A, Ávila-Villegas R, González-Ripoll M, Uberos J, Florido-Navío J, Molina-Carballo A. Melatonin levels during the first week of life and their relation with the antioxidant response in the perinatal period. Neonatology 2007;92:209–216.
   PubMed Web of Science ®Google Scholar
• Tan DX, Manchester LC, Sáinz RM, Mayo JC, León J, Reiter RJ. Physiological ischemia/reperfusion phenomena and their relation to endogenous melatonin production: a hypothesis. Endocrine 2005;27:149–158.
   PubMed Web of Science ®Google Scholar
• Fulia F, Gitto E, Cuzzocrea S, Reiter RJ, Dugo L, Gitto P, Barberi S, Cordaro S, Barberi I. Increased levels of malondialdehyde and nitrite/nitrate in the blood of asphyxiated newborns: reduction by melatonin. J Pineal Res 2001;31:343–349.
   PubMed Web of Science ®Google Scholar
• León J, Acuña-Castroviejo D, Escames G, Tan DX, Reiter RJ. Melatonin mitigates mitochondrial malfunction. J Pineal Res 2005;38:1–9.
   PubMed Web of Science ®Google Scholar
• Gitto E, Karbownik M, Reiter RJ, Tan DX, Cuzzocrea S, Chiurazzi P, Cordaro S, Corona G, Trimarchi G, Barberi I. Effects of melatonin treatment in septic newborns. Pediatr Res 2001;50:756–760.
   PubMed Web of Science ®Google Scholar
• Gitto E, Reiter RJ, Cordaro SP, La Rosa M, Chiurazzi P, Trimarchi G, Gitto P, Calabrò MP, Barberi I. Oxidative and inflammatory parameters in respiratory distress syndrome of preterm newborns: beneficial effects of melatonin. Am J Perinatol 2004;21:209–216.
   PubMed Web of Science ®Google Scholar
• Gitto E, Reiter RJ, Amodio A, Romeo C, Cuzzocrea E, Sabatino G, Buonocore G, Cordaro V, Trimarchi G, Barberi I. Early indicators of chronic lung disease in preterm infants with respiratory distress syndrome and their inhibition by melatonin. J Pineal Res 2004;36:250–255.
   PubMed Web of Science ®Google Scholar
• Gitto E, Romeo C, Reiter RJ, Impellizeri P, Pesce S, Basile M, Antonuccio P, Trimarchi G, Barberi I. Melatonin reduces oxidative stress in surgical neonates. J Pediatr Surg 2004;39:184–189.
   PubMed Web of Science ®Google Scholar
• Cuzzocrea S, Reiter RJ. Melatonin-immune system relationships. Curr Top Med Chem 2002;2:167–180.
   PubMedGoogle Scholar
• Rodríguez MI, Escames G, López LC, Lopez A, Garcia JA, Ortiz F, Acuna-Castroviejo D. Chronic melatonin treatment reduces the age-dependent inflammatory process in senescence-accelerated mice. J Pineal Res 2007;42:272–279.
   PubMed Web of Science ®Google Scholar
• Jung KH, Hong SW, Zheng HM, Lee H, Lee DH, Lee SY, Hong SS. Melatonin ameliorates cerulein-induced pancreatitis by the modulation of nuclear erythroid 2-realted factor 2 and nuclear factor-kappaB in rats. J Pineal Res 2010;48:239–250.
   PubMed Web of Science ®Google Scholar
• Gitto E, Pellegrino S, Gitto P, Barberi I, Reiter RJ. Oxidative stress of the newborn in the pre- and postnatal period and the clinical utility of melatonin. J Pineal Res 2009;46:128–139.
   PubMed Web of Science ®Google Scholar
• Tengattini S, Reiter RJ, Tan DX, Terron MP, Rodella LF, Rezzani R. Cardiovascular diseases: protective effects of melatonin. J Pineal Res 2008;44:16–25.
   PubMed Web of Science ®Google Scholar
• Peschke E. Melatonin, endocrine pancreas and diabetes. J Pineal Res 2008;44:26–40.
   PubMed Web of Science ®Google Scholar
• Jan JE, Reiter RJ, Wasdell MB, Bax M. The role of the thalamus in sleep, pineal melatonin production, and circadian rhythm sleep disorders. J Pineal Res 2009;46:1–7.
   PubMed Web of Science ®Google Scholar
• Sanchez-Barcelo EJ, Mediavilla MD, Tan DX, Reiter RJ. Clinical uses of melatonin: evaluation of clinical trials. Curr Med Chem 2010;17:2070–2095.
   PubMed Web of Science ®Google Scholar
• Chan WY, Ng TB. Development of pre-implantation mouse embryos under the influence of pineal indoles. J Neural Transm Gen Sect 1994;96:19–29.
   PubMed Web of Science ®Google Scholar
• Jahnke G, Marr M, Myers C, Wilson R, Travols G, Price C. Maternal and developmental toxicity evaluation of melatonin administered orally to pregnant Sprague-Dawley rats. Toxicol Sci 1999;50:271–279.
   PubMed Web of Science ®Google Scholar